The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
TED?A9 is part of S.Biomedics’ expanding pipeline of stem-cell-based therapies, developed using the company’s proprietary targeted embryonic stem cell differentiation platform
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Subscribe To Our Newsletter & Stay Updated
